Alphamab Oncology (HKG:9966)

Alphamab Oncology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,305	3,368	6,407	10,149	12,743	15,221
Market Cap Growth	505.42%	-47.42%	-36.88%	-20.36%	-16.28%	21.20%
Enterprise Value	11,803	2,154	5,004	8,763	10,814	12,776
Last Close Price	13.70	3.50	6.64	10.80	13.60	16.28
PE Ratio	52.91	19.03	-	-	-	-
PS Ratio	15.45	4.95	26.58	53.81	71.10	-
PB Ratio	6.55	1.73	3.48	5.76	5.55	5.64
P/TBV Ratio	6.55	1.73	3.48	5.76	5.55	5.64
P/FCF Ratio	55.80	16.61	-	-	-	-
P/OCF Ratio	47.34	14.91	-	-	-	-
EV/Sales Ratio	13.70	3.16	20.76	46.46	60.34	-
EV/EBITDA Ratio	41.51	12.24	-	-	-	-
EV/EBIT Ratio	57.27	20.04	-	-	-	-
EV/FCF Ratio	49.50	10.62	-	-	-	-
Debt / Equity Ratio	0.15	0.10	0.15	0.22	0.34	0.10
Debt / EBITDA Ratio	1.08	1.04	-	-	-	-
Debt / FCF Ratio	-	0.98	-	-	-	-
Asset Turnover	0.35	0.29	0.10	0.07	0.06	-
Inventory Turnover	0.83	0.75	0.77	0.72	0.06	-
Quick Ratio	4.76	6.41	5.55	3.72	3.22	6.52
Current Ratio	4.98	6.74	5.84	3.88	3.32	6.67
Return on Equity (ROE)	13.37%	9.49%	-13.04%	-19.00%	-19.91%	-18.21%
Return on Assets (ROA)	5.22%	2.88%	-9.50%	-11.21%	-9.72%	-9.32%
Return on Capital (ROIC)	5.76%	3.20%	-10.55%	-12.25%	-10.38%	-9.89%
Return on Capital Employed (ROCE)	9.40%	5.10%	-	-	-	-
Earnings Yield	1.92%	5.25%	-3.62%	-3.63%	-3.97%	-3.34%
FCF Yield	1.79%	6.02%	-4.11%	-4.79%	-4.61%	-3.42%
Buyback Yield / Dilution	-3.37%	-2.53%	-2.50%	-0.11%	-0.62%	-73.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.